About Aditi Ganguly
Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do's and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities.
Aditi's fascination with the stock market began in college, where she majored in Economics, while researching The Great Recession for her thesis. After graduating, she began her career handling the content requirements for the mutual fund aggregator Groww. Since then she has become a financial journalist that focuses on writing articles that educate retail investors about the equity markets and the global economy.
Recent Articles By Aditi Ganguly
Is Biogen a Buy, Sell, or Hold?
Pharmaceutical developer Biogen (BIIB) is making substantial progress in its research, which is driving a gradual rise in its share price. However, will the company be able to survive despite a continued decline in its financials? Read more to find out.
Steer Clear of These 4 Cathie Wood Stocks
Cathie Wood’s flagship Ark Innovation ETF (ARKK) has been experiencing a sharp pullback since March. The continuing tech sell-off and rising Treasury yields have sapped the momentum from some of her biggest bets. We think four companies held by ARKK, namely Twilio (TWLO), Teladoc Health (TDOC), CRISPR Therapeutics (CRSP) and Invitae (NVTA), are best avoided now because they are expected to incur hefty losses until next year. Read on.
3 Electric Vehicle Stocks to Avoid at all Costs in Q2
A price retreat by electric vehicle (EV) stocks delivered substantial losses to overvalued, speculative stocks last quarter. And given the rising costs of production and expected decline in oil prices, EV sales are projected to fall in the near term. Thus, we think speculative stocks in the sector, such as Fisker (FSR), Electrameccanica Vehicles (SOLO), and Green Power Motor (GP), are best avoided now.
How KeyCorp Stands Out in the Banking Industry
Banking services company KeyCorp (KEY) is one of the few players in its industry that managed to boost its interest income amid currently record low benchmark rates. But because the ongoing economic recovery could usher in higher inflation, will the company be able to maintain its earnings growth trajectory? Read more to find out.
3 ‘Buy Rated’ Capital Market Stocks to Add to Your Portfolio
The capital markets have been surging since the second half of 2020 with a record number of companies going public last year through IPOs and SPACs. The trend is likely to continue this year as the recovering economy and bullish market sentiment buoy investors’ risk tolerance. Thus, we believe that capital market stocks Raymond James Financial (RJF), Stifel Financial (SF), and Lazard (LAZ) should be valuable additions to one’s portfolio.
Is Recent IPO Compass a Good Buy?
SoftBank-backed Compass (COMP) went public on March 31, 2021 and raised approximately $450 million by selling shares at the lower price range of its downsized offering. However, as one of the few players in the tech-based real estate industry, the question is will COMP be able to navigate through surging volatility in the housing market to deliver robust returns? Read more to find out.
3 High-Yield MLPs to Buy in April
Master limited partnerships (MLPs) are known for their unique tax structure--these companies are not required to pay corporate taxes. Given President Biden’s proposal to raise corporate taxes in the near term, and with current fluctuations in benchmark fixed-income securities, MLPs such as Teekay LNG Partners (TGP), Höegh LNG Partners (HMLP), and Golar LNG Partners (GMLP) are expected to be relatively profitable investment bets, owing to their relatively higher earnings yield. Read on.
PPG Industries: Is Now a Good Time to Buy the Stock?
The world’s second largest paint coating manufacturer, PPG Industries (PPG), reported record financial growth in the most recent quarter. But the stock has seen only modest price gains year-to-date. So, the question is, will the stock gain momentum in the near term to reflect its robust financials? Read more to find out.
Is Genworth Financial a Winner in the Life Insurance Industry?
Shares of Genworth Financial (GNW) have been declining over the past year despite a rising demand for life insurance. However, Wall Street expects the company’s earnings to rise in the coming months. So, will GNW’s stock soar in the near term based on its potential earnings growth? Read more to find out.